AI in Clinical and Molecular Diagnostics Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $5,500	112 Pages	BCC Research	October, 2024	WA19260818

Best Price Guarantee
Price	from $5,500
Length	112 Pages
Publisher	BCC Research
Published Date	October, 2024
SKU	WA19260818

Table of Contents
Description

AI in Clinical and Molecular Diagnostics Market

Report Scope

This report on the global market for AI in clinical and molecular diagnostics entails a comprehensive analysis of the market size, growth trends and segmentation by technology and application. It examines drivers, challenges and opportunities influencing the adoption of AI technologies in clinical and molecular diagnostics, focusing on specific applications in imaging, genomics and laboratory diagnostics. The report provides perspectives on the competitive environment, featuring profiles of leading companies and their strategic initiatives, as well as regional analyses that address the specific market dynamics in North America, Europe, Asia-Pacific, and the Rest of the World (RoW), which in this report includes Latin America and the Middle East and Africa. It also identifies emerging trends, such as the integration of AI in personalized medicine and telehealth. This report is an essential reference for stakeholders, including healthcare providers, technology developers and policymakers, seeking to navigate and capitalize on the evolving AI landscape in diagnostics.

Report Includes

27 data tables and 41 additional tables

An analysis of the current and future global markets for AI in clinical and molecular diagnostics

Analyses of global market trends, with market revenue data (sales figures) for 2021-2023, estimates for 2024, and projected CAGRs through 2029

Estimates of the market size and revenue forecasts for the global market for AI in clinical and molecular diagnostics, with market share analysis by type of services, devices, and region

Discussion of the rising prevalence of chronic diseases, and technological advances in biomarker discovery, disease progression prediction, and personalized treatment strategies

Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies

Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG scores, and consumer attitudes

Competitive intelligence, including companies’ market shares, recent M&A activity and venture funding

Profiles of the leading companies, including Siemens Healthineers AG, F. Hoffmann-La Roche Ltd., Koninklijke Philips N.V., Fujifilm Holdings Corp., and Merative

Companies Mentioned

Atomwise Inc.
Butterfly Network Inc.
F. Hoffmann-la Roche Ltd.
Enlitic
Fujifilm Holdings Corp.
Intel Corp.
Ge Healthcare
Merative
Illumina Inc.
Nvidia Corp.
Koninklijke Philips N.V.
Qure.Ai
Medtronic
Synapsica Healthcare Pvt Ltd.
Microsoft Corp.
Siemens Healthineers Ag
Thermo Fisher Scientific Inc.

Chapter 1 Executive Summary: Market Outlook; Scope of Report; Market Summary
Chapter 2 Market Overview: Overview; History of AI; Rise of Machine Learning; Machine Learning vs. Deep Learning vs. Neural Networks; Types of Machine Learning; Advantages and Disadvantages of ML Algorithms; AI in Healthcare; AI in Clinical Diagnostics; AI in Molecular Diagnostics
Chapter 3 Market Dynamics: Overview; Market Drivers; Investment in the AI Health Sector; Increasing Prevalence of Chronic and Infectious Diseases; Technological Advances; Demand for Personalized Medicine; Market Restraints; Practitioners Reluctant to Adopt AI-based Technologies; Data Security; Regulatory Challenges; Market Opportunities; Software with AI; Untapped Opportunities in Developing Markets
Chapter 4 Regulatory Structure
Chapter 5 Emerging Technologies and Developments: Latest Technologies/Developments; Machine Learning Algorithms; Deep Learning; Generative AI; Natural Language Processing (NLP); Genomic AI; Cloud-Based Solutions
Chapter 6 Market Segmentation Analysis: Market Trends; Segmentation Breakdown; AI in Clinical and Molecular Diagnostics: Global Markets; Molecular Diagnostics; Clinical Diagnostics; Market Analysis by Component; Software; Services; Hardware; Geographic Breakdown; Market Analysis by Region; North America; Europe; Asia-Pacific; Rest of the World
Chapter 7 Competitive Intelligence
Chapter 8 Sustainability in AI in Clinical and Molecular Diagnostics: An ESG Perspective: Environmental Sustainability; Positive Environmental Impacts; Negative Environmental Impacts; Social: Ensuring that AI Benefits All Society; Governance Impacts
Chapter 9 Appendix: Methodology; Sources; Abbreviations; Company Profiles; ATOMWISE INC.; F. HOFFMANN-LA ROCHE LTD.; FUJIFILM HOLDINGS CORP.; GE HEALTHCARE; ILLUMINA INC.; KONINKLIJKE PHILIPS N.V.; MEDTRONIC; MICROSOFT CORP.; SIEMENS HEALTHINEERS AG; THERMO FISHER SCIENTIFIC INC.; Vendors; BUTTERFLY NETWORK INC.; ENLITIC; INTEL CORP.; MERATIVE; NVIDIA CORP.; QURE.AI; SYNAPSICA HEALTHCARE PVT LTD.